184 related articles for article (PubMed ID: 9920842)
41. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
42. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
[TBL] [Abstract][Full Text] [Related]
43. How do cytotoxic lymphocytes kill their targets?
Shresta S; Pham CT; Thomas DA; Graubert TA; Ley TJ
Curr Opin Immunol; 1998 Oct; 10(5):581-7. PubMed ID: 9794837
[TBL] [Abstract][Full Text] [Related]
44. Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells.
Hayashida M; Kawano H; Nakano T; Shiraki K; Suzuki A
Proc Soc Exp Biol Med; 2000 Nov; 225(2):143-50. PubMed ID: 11044257
[TBL] [Abstract][Full Text] [Related]
45. Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.
Sharma VK; Bologa RM; Li B; Xu GP; Lagman M; Hiscock W; Mouradian J; Wang J; Serur D; Rao VK; Suthanthiran M
Transplantation; 1996 Dec; 62(12):1860-6. PubMed ID: 8990377
[TBL] [Abstract][Full Text] [Related]
46. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression.
Matter-Reissmann UB; Forte P; Schneider MK; Filgueira L; Groscurth P; Seebach JD
Xenotransplantation; 2002 Sep; 9(5):325-37. PubMed ID: 12199864
[TBL] [Abstract][Full Text] [Related]
47. Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2.
Zheng L; Ben LH; Pober JS; Bothwell AL
J Immunol; 2002 Dec; 169(12):6850-5. PubMed ID: 12471117
[TBL] [Abstract][Full Text] [Related]
48. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
49. Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules.
Troye-Blomberg M; Worku S; Tangteerawatana P; Jamshaid R; Söderström K; Elghazali G; Moretta L; Hammarström M; Mincheva-Nilsson L
Scand J Immunol; 1999 Dec; 50(6):642-50. PubMed ID: 10607313
[TBL] [Abstract][Full Text] [Related]
50. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.
Graubert TA; DiPersio JF; Russell JH; Ley TJ
J Clin Invest; 1997 Aug; 100(4):904-11. PubMed ID: 9259590
[TBL] [Abstract][Full Text] [Related]
51. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
Kaneda R; Iwabuchi K; Onoé K
Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
[TBL] [Abstract][Full Text] [Related]
52. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
[TBL] [Abstract][Full Text] [Related]
53. T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms.
Hsieh MH; Patterson AE; Korngold R
Biol Blood Marrow Transplant; 2000; 6(3):231-40. PubMed ID: 10871148
[TBL] [Abstract][Full Text] [Related]
54. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.
Lee RK; Spielman J; Podack ER
Int Immunol; 1996 Jul; 8(7):991-1000. PubMed ID: 8757944
[TBL] [Abstract][Full Text] [Related]
55. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
Lancki DW; Hsieh CS; Fitch FW
J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
[TBL] [Abstract][Full Text] [Related]
57. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway.
Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R
J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607
[TBL] [Abstract][Full Text] [Related]
58. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
Liu ZX; Govindarajan S; Okamoto S; Dennert G
J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
[TBL] [Abstract][Full Text] [Related]
59. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes.
Corazza N; Müller S; Brunner T; Kägi D; Mueller C
J Immunol; 2000 Jan; 164(1):398-403. PubMed ID: 10605035
[TBL] [Abstract][Full Text] [Related]
60. Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes.
Makita M; Azuma T; Hamaguchi H; Niiya H; Kojima K; Fujita S; Tanimoto M; Harada M; Yasukawa M
Leukemia; 2002 Dec; 16(12):2400-7. PubMed ID: 12454745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
